BractonDeal Intel
Get full access
AcquisitionOther

Lexeo Therapeutics, Inc. acquired Mantle Therapeutics

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

Lexeo Therapeutics, Inc. -> Mantle Therapeutics · $8.3 million

Together, these transactions will simultaneously expand Lexeo's vision and capabilities beyond gene therapy, deepen the company’s focus on the multisystem burden of FA, and add multiple therapeutic approaches designed to increase or restore frataxin in the bra

Open source record (SEC) ↗
Bracton Partners

Sell-side M&A advisory for software, fintech and data companies. Everything on these pages is built from primary sources: SEC filings, company announcements, and the public record. No estimates and no unnamed sources.

bractonpartners.comApproachForm D monitorDisclosures

M&A advisory only. No capital-raising services are offered. Nothing on this page is a valuation, a recommendation, or an offer of any security.